Sibold William John 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Sibold William John
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-09-09$445.63/sh−7,279$3,243,741→ 102,474 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.